Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, IDEX Biometrics ASA's enterprise value is kr668.11 Mil.
IDEX Biometrics ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-74.70 Mil. Therefore, IDEX Biometrics ASA's EV-to-EBITDA for today is -8.94.
The historical rank and industry rank for IDEX Biometrics ASA's EV-to-EBITDA or its related term are showing as below:
OSL:IDEX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -20.74 Med: -4.33 Max: -0.19
Current: -8.94
During the past 13 years, the highest EV-to-EBITDA of IDEX Biometrics ASA was -0.19. The lowest was -20.74. And the median was -4.33.
OSL:IDEX's EV-to-EBITDA is ranked worse than 100% of 1957
companies
in the Software industry
Industry Median: 10.4
vs OSL:IDEX: -8.94
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IDEX Biometrics ASA's PE Ratio (TTM) for today is calculated as:
IDEX Biometrics ASA's share price for today is kr8.66.
IDEX Biometrics ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.109.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for IDEX Biometrics ASA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:IDEX vs QH, SHOP, UBER: EV-to-EBITDA Comparison
For the Software - Application subindustry, IDEX Biometrics ASA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEX Biometrics ASA EV-to-EBITDA vs Software Industry
For the Software industry and Technology sector, IDEX Biometrics ASA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where IDEX Biometrics ASA's EV-to-EBITDA falls into.
IDEX Biometrics ASA's current Enterprise Value is kr668.11 Mil.
IDEX Biometrics ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-74.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEX Biometrics ASA (OSL:IDEX) has a EV-to-EBITDA of -8.94 as of Jul. 29, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on IDEX Biometrics ASA. According to the industry distribution chart, IDEX Biometrics ASA ranks #999999 out of 1957 companies in the Software industry.
Is IDEX Biometrics ASA's EV-to-EBITDA too high?
IDEX Biometrics ASA's current EV-to-EBITDA is -8.94. Based on the distribution chart, IDEX Biometrics ASA ranks #999999 out of 1957 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, IDEX Biometrics ASA has a GF Score™ of 20/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IDEX Biometrics ASA's EV-to-EBITDA compare to QH and SHOP?
According to the Software industry distribution chart, IDEX Biometrics ASA ranks #999999 out of 1957 companies for EV-to-EBITDA. This places IDEX Biometrics ASA in the lower half of its industry. The industry median EV-to-EBITDA is 10.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Software company?
The median EV-to-EBITDA among Software companies is 10.40, based on 1,957 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on IDEX Biometrics ASA. For the Software industry, the median EV-to-EBITDA is 10.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEX Biometrics ASA's current EV-to-EBITDA is -8.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEX Biometrics ASA stock overvalued right now?
Based on GuruFocus' analysis, IDEX Biometrics ASA (OSL:IDEX) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.52, compared to a current price of kr8.66 — trading 1565.4% above its estimated fair value. The current EV-to-EBITDA is -8.94. IDEX Biometrics ASA's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For IDEX Biometrics ASA (OSL:IDEX), the current EV-to-EBITDA is -8.94 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEX Biometrics ASA (OSL:IDEX) Overvalued in 2026?
Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued.
The current stock price of kr8.66 is trading 1565.4% above its estimated GF Value™ of kr0.52.
GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.
Key valuation signals for OSL:IDEX:
EV-to-EBITDA: -8.94
GF Value™: kr0.52 vs. price of kr8.66 (1565.4% above fair value)
No single metric tells the full story. See the OSL:IDEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.
20GF Score
Get the complete analysis for OSL:IDEX
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:IDEX has been successfully added to your 
